
Fatty Acids and Lypidic Derivatives
Fatty acids are molecules composed of a long hydrocarbon chain with a carboxyl (-COOH) group at one end. These structures grant them a high capacity to interact with cell membranes and play key roles in energy metabolism, fat storage, and hormonal regulation. Fatty acid derivatives are used in cosmetics, pharmaceuticals, and as components in the production of biofuels.
At CymitQuimica, we offer fatty acids and their derivatives for applications in organic chemistry, biochemistry, and pharmaceutical development.
Found 32241 products of "Fatty Acids and Lypidic Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
3-Hydroxy-7,12-diketocholanoic Acid
CAS:Controlled Product<p>Applications 3-Hydroxy-7,12-diketocholanoic Acid is a bile acid salt as biosurfactants.<br>References Posa, M., et al.: Steroids, 86, 16-25 (2014)<br></p>Formula:C24H36O5Color and Shape:NeatMolecular weight:404.54α-Muricholic Acid
CAS:Controlled Product<p>Applications α-Muricholic Acid is an bile acid found in urine. Studies have linked α-Muricholic in the understanding of the complex signaling pathways of hepatic lipid abnormalities with type 2 diabetes and a treatment target for this condition.<br>References Haeusier, R.A., et al.: Cell. Metabolism., 15, 65 (2012); Chen, K.H., et al.: Am. J. Physiol., 301, E853 (2011);<br></p>Formula:C24H40O5Color and Shape:NeatMolecular weight:408.578-benzyl-4-heptanoyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid
CAS:Purity:95.0%Molecular weight:388.507995605468754-Hydroxy Atorvastatin-d5 Disodium Salt
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A deuterated metabolite of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.<br>References Smith, S., et al.: Am. J. Cardiol., 80, 10H (1997), Jacobsen, W., et al.: Drug Metab. Dispos., 28, 1369 (2000), Istvan, E., et al.: Science, 292, 1160 (2001), Tabernero, L., et al.: J. Biol. Chem., 278, 19933 (2003), Bratton, L., et al.: Bioorg. Med. Chem., 15, 5576 (2007),<br></p>Formula:C33H28D5FN2Na2O6Color and Shape:NeatMolecular weight:623.63Succinic Acid
CAS:<p>Applications Succinic Acid was identified in essential oil from Saxifraga stolonifera and has antibacterial activity.<br>References Zhang, Z.: Xibei Nongye Xuebao, 25, 1536 (2016)<br></p>Formula:C4H6O4Color and Shape:NeatMolecular weight:118.09L-Hydantoin-5-propionic Acid
CAS:Controlled ProductFormula:C6H8N2O4Color and Shape:NeatMolecular weight:172.14Misoprostol
CAS:Controlled Product<p>Applications Misoprostol is a cytoprotective prostaglandin PGE1 analogue.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Graham, Y., et al.: Lancet, 2, 1277 (1988); Graham, D.Y., et al.: Ann. Int. Med., 119, 257 (1993); Fletcher, H., et al.: Obstet. Gynecol., 83, 244 (1994);<br></p>Formula:C22H38O5Color and Shape:Light Yellow ViscousMolecular weight:382.53(S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxamide
CAS:Controlled Product<p>Applications (S)-1-(2-Chloroacetyl)pyrrolidine-2-carboxamide is used in the synthesis of Vildagliptin (V305000), an oral anti-diabetic drug, and its impurities (H971380) (Impurity A).<br>References Kumar, N., et al.: J. Pharmaceut. Biomed.,119, 114 (2016); Deng, Y., et al.: Lett. Org. Chem., 11, 780 (2014);<br></p>Formula:C7H11ClN2O2Color and Shape:NeatMolecular weight:190.63Taurultam
CAS:Controlled Product<p>Applications Taurultam is a compound that inhibits cell proliferation and cell adhesion in angiogenesis. Taurultam exhibits bacteriocidal effects on Escherichia coli and is also a degradation product of Taurolidine (T009050).<br>References Jones, D., et al.: Lett. Appl. Micro., 14, 5 (1992); Kirsch, L. & Sinn, Y.: Pharm. Dev. Tech., 2, 345 (1997); Mšhler, T., et al.: Cancer Therapy, 6, 623 (2008)<br></p>Formula:C3H8N2O2SColor and Shape:White To Off-WhiteMolecular weight:136.17Tadalafil Ketolactam (>90%)
CAS:Controlled Product<p>Stability Hygroscopic, Unstable in Solution<br>Applications Tadalafil Ketolactam is a Tadalafil (T004500) impurity.<br></p>Formula:C22H19N3O6Purity:>90%Color and Shape:NeatMolecular weight:421.4028Glutaric Acid
CAS:<p>Applications Glutaric Acid is an organic acid found in human urine which may be used for the detection of metabolic or other health disorders.<br>References Christou, C., et. al.: J. Chromatogr. B. Anal. Tech. Biomed. Life Sci., 964, 195 (2014)<br></p>Formula:C5H8O4Color and Shape:White PowderMolecular weight:132.11(1S,3R)-Methyl-1,2,3,4-tetrahydro-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate
CAS:Controlled Product<p>Applications An intermediate in the synthesis of thephosphodiesterase 5 inhibitor Tadalafil (T004500).<br>References Carrier, S., et al.: Can. J. Urol., 10(1), 12 (2003),<br></p>Formula:C20H18N2O4Color and Shape:White To YellowMolecular weight:350.37(3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone
CAS:Controlled Product<p>Impurity Orlistat USP Related Compound A<br>Applications (3S,4S)-3-Hexyl-4-[(2R)-2-hydroxytridecyl]-2-oxetanone (Orlistat USP Related Compound A) is an analog of Tetrahydrolipstatin, an inhibitor of the hydrolysis of endocannabinoid 2-arachidonoylglycerol (2-AG), also an intermediate in the preparation of Orlistat (O686500).<br>References Mechoulam, R., et al.: Biochem. Pharmacol., 50, 83 (1995), Bisogno, T., et al.: J. Cell Biol., 163, 463 (2003), Di Marzo, V., et al.: Nat. Rev. Drug Discovery, 7, 438 (2008), Ortar, G., et al.: J. Med. Chem., 51, 6970 (2008),<br></p>Formula:C22H42O3Color and Shape:NeatMolecular weight:354.574-(2-phenylbutanoyl)-8-propyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid
CAS:Purity:95.0%Molecular weight:374.48098754882814-Hydroxy Atorvastatin Hemicalcium Salt
CAS:<p>Applications 4-Hydroxyatorvastatin is a hydroxylated metabolite of Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastatin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.<br>References Smith, S. et al.: Am. J. Cardiol., 80, 10H (1997); Jacobsen, W. et al.: Drug Metab. Dispos., 28, 1369 (2000); Istvan, E. et al.: Science, 292, 1160 (2001); Tabernero, L. et al.: J. Biol. Chem., 278, 19933 (2003); Bratton, L. et al.: Bioorg. Med. Chem., 15, 5576 (2007);<br></p>Formula:C66H68CaF2N4O12Purity:>90%Color and Shape:NeatMolecular weight:1187.34

